전자 처방전 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The E-Prescribing Market size is expected to reach USD 53.38 Billion in 2034 from USD 6.12 Billion (2025) growing at a CAGR of 27.21% during 2026-2034.

The global e-prescribing market has grown rapidly as healthcare providers adopt digital solutions to improve prescription management. E-prescribing systems allow physicians to generate and send prescriptions electronically to pharmacies, reducing paperwork and minimizing medication errors. These systems improve efficiency in healthcare operations and enhance patient safety.

Several factors are driving the growth of the e-prescribing market. Government initiatives promoting digital healthcare systems and electronic medical records are encouraging the adoption of electronic prescribing solutions. Additionally, the increasing need to reduce prescription errors and improve medication tracking has strengthened demand for these technologies.

Looking ahead, the e-prescribing market is expected to expand as healthcare systems continue to digitize medical processes. Integration with electronic health records and pharmacy management systems will enhance system functionality. As healthcare providers focus on improving patient care and operational efficiency, electronic prescribing solutions will remain essential tools.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Solutions (Integrated Solutions, Standalone Solutions)
• Services (Support, Implementation, Training, Network)

By Delivery Mode

• Web/Cloud-Based
• On-premise

By End-use

• Hospital
• Office-based Physicians
• Pharmacy

By Usage Methods

• Handheld
• Computer Based Devices

By Substances

• Controlled Substances
• Non-controlled Substances

By Specialties

• Oncology
• Sports Medicine
• Neurology
• Cardiology
• Others

COMPANIES PROFILED

• Cerner Corporation Oracle, Allscripts Healthcare LLC, Epic Systems Corporation, DrFirst, Athenahealth, NXGN Management LLC, McKesson Corporation, Surescripts, Change Healthcare, Practice Fusion Inc, Networking Technology Inc RXNT
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL E-PRESCRIBING MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Solutions (Integrated Solutions, Standalone Solutions) Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services (Support, Implementation, Training, Network) Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL E-PRESCRIBING MARKET: BY DELIVERY MODE 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Delivery Mode
• 5.2. Web/Cloud-Based Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. On-premise Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL E-PRESCRIBING MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospital Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Office-based Physicians Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Pharmacy Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL E-PRESCRIBING MARKET: BY USAGE METHODS 2022-2034 (USD MN)

• 7.1. Market Analysis, Insights and Forecast Usage Methods
• 7.2. Handheld Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 7.3. Computer Based Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 8. GLOBAL E-PRESCRIBING MARKET: BY SUBSTANCES 2022-2034 (USD MN)

• 8.1. Market Analysis, Insights and Forecast Substances
• 8.2. Controlled Substances Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 8.3. Non-controlled Substances Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 9. GLOBAL E-PRESCRIBING MARKET: BY SPECIALTIES 2022-2034 (USD MN)

• 9.1. Market Analysis, Insights and Forecast Specialties
• 9.2. Oncology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.3. Sports Medicine Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.4. Neurology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.5. Cardiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 9.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 10. GLOBAL E-PRESCRIBING MARKET: BY REGION 2022-2034(USD MN)

• 10.1. Regional Outlook
• 10.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.2.1 By Product
  • 10.2.2 By Delivery Mode
  • 10.2.3 By End-use
  • 10.2.4 By Usage Methods
  • 10.2.5 By Substances
  • 10.2.6 By Specialties
  • 10.2.7 United States
  • 10.2.8 Canada
  • 10.2.9 Mexico
• 10.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.3.1 By Product
  • 10.3.2 By Delivery Mode
  • 10.3.3 By End-use
  • 10.3.4 By Usage Methods
  • 10.3.5 By Substances
  • 10.3.6 By Specialties
  • 10.3.7 United Kingdom
  • 10.3.8 France
  • 10.3.9 Germany
  • 10.3.10 Italy
  • 10.3.11 Russia
  • 10.3.12 Rest Of Europe
• 10.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.4.1 By Product
  • 10.4.2 By Delivery Mode
  • 10.4.3 By End-use
  • 10.4.4 By Usage Methods
  • 10.4.5 By Substances
  • 10.4.6 By Specialties
  • 10.4.7 India
  • 10.4.8 Japan
  • 10.4.9 South Korea
  • 10.4.10 Australia
  • 10.4.11 South East Asia
  • 10.4.12 Rest Of Asia Pacific
• 10.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.5.1 By Product
  • 10.5.2 By Delivery Mode
  • 10.5.3 By End-use
  • 10.5.4 By Usage Methods
  • 10.5.5 By Substances
  • 10.5.6 By Specialties
  • 10.5.7 Brazil
  • 10.5.8 Argentina
  • 10.5.9 Peru
  • 10.5.10 Chile
  • 10.5.11 South East Asia
  • 10.5.12 Rest of Latin America
• 10.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 10.6.1 By Product
  • 10.6.2 By Delivery Mode
  • 10.6.3 By End-use
  • 10.6.4 By Usage Methods
  • 10.6.5 By Substances
  • 10.6.6 By Specialties
  • 10.6.7 Saudi Arabia
  • 10.6.8 UAE
  • 10.6.9 Israel
  • 10.6.10 South Africa
  • 10.6.11 Rest of the Middle East And Africa

Chapter 11. COMPETITIVE LANDSCAPE

• 11.1. Recent Developments
• 11.2. Company Categorization
• 11.3. Supply Chain & Channel Partners (based on availability)
• 11.4. Market Share & Positioning Analysis (based on availability)
• 11.5. Vendor Landscape (based on availability)
• 11.6. Strategy Mapping

Chapter 12. COMPANY PROFILES OF GLOBAL E-PRESCRIBING INDUSTRY

• 12.1. Top Companies Market Share Analysis
• 12.2. Company Profiles
  • 12.2.1 Cerner Corporation (Oracle)
  • 12.2.2 Allscripts Healthcare LLC
  • 12.2.3 Epic Systems Corporation
  • 12.2.4 DrFirst
  • 12.2.5 Athenahealth
  • 12.2.6 NXGN Management LLC
  • 12.2.7 McKesson Corporation
  • 12.2.8 Surescripts
  • 12.2.9 Change Healthcare
  • 12.2.10 Practice Fusion Inc
  • 12.2.11 Networking Technology Inc. (RXNT)